1. Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma;ANDERSSON;Thrombosis Research,1979
2. Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously;BERGQVIST;Thrombosis Research,1983
3. Characterization of a new potent heparin;BHARGAVA;Arzneimittelforschung/Drug Research,1981
4. Pharmakokinetik des niedermolekularen Heparins Fragmin®D beim Hund;GREBE;Berliner und Münchner Tierärztliche Wochenschrift,2000
5. Activated coagulation time in monitoring heparinized dogs;GREEN;American Journal of Veterinary Research,1980